Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 124

1.

Transient postnatal over nutrition induces long-term alterations in cardiac NLRP3-inflammasome pathway.

Siddeek B, Li N, Mauduit C, Chehade H, Rigal E, Tolsa JF, Armengaud JB, Yzydorczyk C, Benahmed M, Vergely C, Simeoni U.

Nutr Metab Cardiovasc Dis. 2018 Sep;28(9):944-951. doi: 10.1016/j.numecd.2018.03.013. Epub 2018 Apr 14.

PMID:
29752038
2.

Redox Functions of Heme Oxygenase-1 and Biliverdin Reductase in Diabetes.

Rochette L, Zeller M, Cottin Y, Vergely C.

Trends Endocrinol Metab. 2018 Feb;29(2):74-85. doi: 10.1016/j.tem.2017.11.005. Epub 2017 Dec 14. Review.

PMID:
29249571
3.

Temporal trends in the premorbid use of preventive treatments in patients with acute ischemic cerebrovascular events and a history of vascular disease: The Dijon Stroke Registry (1985-2010).

Khoumri C, Bailly H, Delpont B, Daubail B, Blanc C, Chazalon C, Durier J, Hervieu-Bègue M, Osseby GV, Rouaud O, Giroud M, Vergely C, Béjot Y.

Presse Med. 2017 Dec;46(12 Pt 1):e259-e267. doi: 10.1016/j.lpm.2017.01.025. Epub 2017 Nov 22.

PMID:
29174475
4.

Transient postnatal overfeeding causes liver stress-induced premature senescence in adult mice.

Yzydorczyk C, Li N, Chehade H, Mosig D, Bidho M, Keshavjee B, Armengaud JB, Nardou K, Siddeek B, Benahmed M, Vergely C, Simeoni U.

Sci Rep. 2017 Oct 10;7(1):12911. doi: 10.1038/s41598-017-11756-2.

5.

The role of osteoprotegerin in the crosstalk between vessels and bone: Its potential utility as a marker of cardiometabolic diseases.

Rochette L, Meloux A, Rigal E, Zeller M, Cottin Y, Vergely C.

Pharmacol Ther. 2018 Feb;182:115-132. doi: 10.1016/j.pharmthera.2017.08.015. Epub 2017 Sep 1. Review.

PMID:
28867452
6.

Hans Selye and the stress response: 80 years after his "letter" to the Editor of Nature.

Rochette L, Vergely C.

Ann Cardiol Angeiol (Paris). 2017 Sep;66(4):181-183. doi: 10.1016/j.ancard.2017.04.017. Epub 2017 Jul 29. No abstract available.

PMID:
28760543
7.

La transition de l’enfant atteint de cancer, regard des familles.

Vergely C.

Soins Pediatr Pueric. 2017 Jul - Aug;38(297):29-31. doi: 10.1016/j.spp.2017.05.008. French.

PMID:
28705566
8.

Relation between high levels of myeloperoxidase in the culprit artery and microvascular obstruction, infarct size and reverse remodeling in ST-elevation myocardial infarction.

Stamboul K, Zeller M, Rochette L, Cottin Y, Cochet A, Leclercq T, Porot G, Guenancia C, Fichot M, Maillot N, Vergely C, Lorgis L.

PLoS One. 2017 Jul 13;12(7):e0179929. doi: 10.1371/journal.pone.0179929. eCollection 2017.

9.

Implications of excess weight in the cardiotoxicity of anthracyclines and trastuzumab in breast cancer.

Guenancia C, Ladoire S, Ghiringelli F, Rochette L, Vergely C, Cottin Y.

Arch Cardiovasc Dis. 2017 Feb;110(2):69-71. doi: 10.1016/j.acvd.2016.12.004. Epub 2017 Feb 16. No abstract available.

10.

Increased Symmetric Dimethylarginine Level Is Associated with Worse Hospital Outcomes through Altered Left Ventricular Ejection Fraction in Patients with Acute Myocardial Infarction.

Lorin J, Guilland JC, Stamboul K, Guenancia C, Cottin Y, Rochette L, Vergely C, Zeller M.

PLoS One. 2017 Jan 26;12(1):e0169979. doi: 10.1371/journal.pone.0169979. eCollection 2017.

11.

Reply to Z. Cheraghi et al.

Guenancia C, Cottin Y, Vergely C, Lebfevre A.

J Clin Oncol. 2017 Mar 10;35(8):924-925. doi: 10.1200/JCO.2016.71.3842. Epub 2017 Jan 23. No abstract available.

PMID:
28113011
12.

TLR4/IFNγ pathways induce tumor regression via NOS II-dependent NO and ROS production in murine breast cancer models.

Lamrani M, Sassi N, Paul C, Yousfi N, Boucher JL, Gauthier N, Labbé J, Seignez C, Racoeur C, Athias A, Guerreiro R, Vergely C, Rochette L, Bettaieb A, Jeannin JF.

Oncoimmunology. 2015 Dec 29;5(5):e1123369. doi: 10.1080/2162402X.2015.1123369. eCollection 2016 May.

13.

Short-term moderate diet restriction in adulthood can reverse oxidative, cardiovascular and metabolic alterations induced by postnatal overfeeding in mice.

Li N, Guenancia C, Rigal E, Hachet O, Chollet P, Desmoulins L, Leloup C, Rochette L, Vergely C.

Sci Rep. 2016 Jul 28;6:30817. doi: 10.1038/srep30817.

14.

Obesity As a Risk Factor for Anthracyclines and Trastuzumab Cardiotoxicity in Breast Cancer: A Systematic Review and Meta-Analysis.

Guenancia C, Lefebvre A, Cardinale D, Yu AF, Ladoire S, Ghiringhelli F, Zeller M, Rochette L, Cottin Y, Vergely C.

J Clin Oncol. 2016 Sep 10;34(26):3157-65. doi: 10.1200/JCO.2016.67.4846. Epub 2016 Jul 25. Review.

15.

"Pro-youthful" factors in the "labyrinth" of cardiac rejuvenation.

Rochette L, Vergely C.

Exp Gerontol. 2016 Oct;83:1-5. doi: 10.1016/j.exger.2016.07.004. Epub 2016 Jul 15. Review.

PMID:
27426744
16.

Letter to the editor: "Doxorubicin and ErbB2 overexpression: another piece in the mitochondrial jigsaw".

Guenancia C, Li N, Rochette L, Vergely C.

Am J Physiol Heart Circ Physiol. 2016 May 1;310(9):H1275-6. doi: 10.1152/ajpheart.00179.2016. No abstract available.

17.

Cerebral microbleeds: A clinical issue for cardiologists?

Dupont G, Daubail B, Vergely C, Cottin Y, Giroud M, Béjot Y.

Arch Cardiovasc Dis. 2016 May;109(5):299-302. doi: 10.1016/j.acvd.2016.01.004. Epub 2016 Mar 15. No abstract available.

18.

Overweight in mice, induced by perinatal programming, exacerbates doxorubicin and trastuzumab cardiotoxicity.

Guenancia C, Hachet O, Aboutabl M, Li N, Rigal E, Cottin Y, Rochette L, Vergely C.

Cancer Chemother Pharmacol. 2016 Apr;77(4):777-85. doi: 10.1007/s00280-016-2995-9. Epub 2016 Feb 25.

PMID:
26914236
19.

Coronary artery disease: Can aminothiols be distinguished from reactive oxygen species?

Rochette L, Vergely C.

Nat Rev Cardiol. 2016 Mar;13(3):128-30. doi: 10.1038/nrcardio.2016.20. Epub 2016 Feb 11. No abstract available.

PMID:
26864913
20.

Growth and differentiation factor 11 (GDF11): Functions in the regulation of erythropoiesis and cardiac regeneration.

Rochette L, Zeller M, Cottin Y, Vergely C.

Pharmacol Ther. 2015 Dec;156:26-33. doi: 10.1016/j.pharmthera.2015.10.006. Epub 2015 Oct 30. Review.

PMID:
26523637
21.

Alpha-lipoic acid: molecular mechanisms and therapeutic potential in diabetes.

Rochette L, Ghibu S, Muresan A, Vergely C.

Can J Physiol Pharmacol. 2015 Dec;93(12):1021-7. doi: 10.1139/cjpp-2014-0353. Epub 2015 Sep 25. Review.

PMID:
26406389
22.

Atrial Fibrillation Is Associated with a Marker of Endothelial Function and Oxidative Stress in Patients with Acute Myocardial Infarction.

Stamboul K, Lorin J, Lorgis L, Guenancia C, Beer JC, Touzery C, Rochette L, Vergely C, Cottin Y, Zeller M.

PLoS One. 2015 Jul 9;10(7):e0131439. doi: 10.1371/journal.pone.0131439. eCollection 2015.

23.

Pre-operative growth differentiation factor 15 as a novel biomarker of acute kidney injury after cardiac bypass surgery.

Guenancia C, Kahli A, Laurent G, Hachet O, Malapert G, Grosjean S, Girard C, Vergely C, Bouchot O.

Int J Cardiol. 2015 Oct 15;197:66-71. doi: 10.1016/j.ijcard.2015.06.012. Epub 2015 Jun 17.

PMID:
26113476
24.

Low Circulating Levels of Growth Differentiation Factor-15 Before Coronary Artery Bypass Surgery May Predict Postoperative Atrial Fibrillation.

Bouchot O, Guenancia C, Kahli A, Pujos C, Malapert G, Vergely C, Laurent G.

J Cardiothorac Vasc Anesth. 2015 Oct;29(5):1131-9. doi: 10.1053/j.jvca.2015.01.023. Epub 2015 Jan 9.

PMID:
25990268
25.

Anthracyclines/trastuzumab: new aspects of cardiotoxicity and molecular mechanisms.

Rochette L, Guenancia C, Gudjoncik A, Hachet O, Zeller M, Cottin Y, Vergely C.

Trends Pharmacol Sci. 2015 Jun;36(6):326-48. doi: 10.1016/j.tips.2015.03.005. Epub 2015 Apr 17. Review.

PMID:
25895646
26.

Toll-like receptor 5 deficiency exacerbates cardiac injury and inflammation induced by myocardial ischaemia-reperfusion in the mouse.

Parapanov R, Lugrin J, Rosenblatt-Velin N, Feihl F, Waeber B, Milano G, Vergely C, Li N, Pacher P, Liaudet L.

Clin Sci (Lond). 2015 Jul;129(2):187-98. doi: 10.1042/CS20140444.

PMID:
25757463
27.

Paradoxically, iron overload does not potentiate doxorubicin-induced cardiotoxicity in vitro in cardiomyocytes and in vivo in mice.

Guenancia C, Li N, Hachet O, Rigal E, Cottin Y, Dutartre P, Rochette L, Vergely C.

Toxicol Appl Pharmacol. 2015 Apr 15;284(2):152-62. doi: 10.1016/j.taap.2015.02.015. Epub 2015 Feb 21.

PMID:
25711856
28.

Cutting edge: IL-1α is a crucial danger signal triggering acute myocardial inflammation during myocardial infarction.

Lugrin J, Parapanov R, Rosenblatt-Velin N, Rignault-Clerc S, Feihl F, Waeber B, Müller O, Vergely C, Zeller M, Tardivel A, Schneider P, Pacher P, Liaudet L.

J Immunol. 2015 Jan 15;194(2):499-503. doi: 10.4049/jimmunol.1401948. Epub 2014 Dec 10.

29.

The iron-regulatory hormone hepcidin: a possible therapeutic target?

Rochette L, Gudjoncik A, Guenancia C, Zeller M, Cottin Y, Vergely C.

Pharmacol Ther. 2015 Feb;146:35-52. doi: 10.1016/j.pharmthera.2014.09.004. Epub 2014 Sep 7. Review.

PMID:
25205158
30.

Growth differentiation factor-15 (GDF-15) levels are associated with cardiac and renal injury in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass.

Kahli A, Guenancia C, Zeller M, Grosjean S, Stamboul K, Rochette L, Girard C, Vergely C.

PLoS One. 2014 Aug 29;9(8):e105759. doi: 10.1371/journal.pone.0105759. eCollection 2014.

31.

Diabetes, oxidative stress and therapeutic strategies.

Rochette L, Zeller M, Cottin Y, Vergely C.

Biochim Biophys Acta. 2014 Sep;1840(9):2709-29. doi: 10.1016/j.bbagen.2014.05.017. Epub 2014 Jun 4. Review.

PMID:
24905298
32.

Iron, oxidative stress, and redox signaling in the cardiovascular system.

Gudjoncik A, Guenancia C, Zeller M, Cottin Y, Vergely C, Rochette L.

Mol Nutr Food Res. 2014 Aug;58(8):1721-38. doi: 10.1002/mnfr.201400036. Epub 2014 May 30. Review.

PMID:
24888568
33.

Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets?

Rochette L, Lorin J, Zeller M, Guilland JC, Lorgis L, Cottin Y, Vergely C.

Pharmacol Ther. 2013 Dec;140(3):239-57. doi: 10.1016/j.pharmthera.2013.07.004. Epub 2013 Jul 13. Review.

PMID:
23859953
34.

High levels of asymmetric dimethylarginine are strongly associated with low HDL in patients with acute myocardial infarction.

Lorin J, Guilland JC, Korandji C, Touzery C, Bichat F, Chagnon A, Cottin Y, Rochette L, Vergely C, Zeller M.

PLoS One. 2013 Jun 6;8(6):e64796. doi: 10.1371/journal.pone.0064796. Print 2013.

35.

Arginine and nitric oxide synthase: regulatory mechanisms and cardiovascular aspects.

Lorin J, Zeller M, Guilland JC, Cottin Y, Vergely C, Rochette L.

Mol Nutr Food Res. 2014 Jan;58(1):101-16. doi: 10.1002/mnfr.201300033. Epub 2013 Jun 6. Review.

PMID:
23740826
36.

Postnatal overfeeding causes early shifts in gene expression in the heart and long-term alterations in cardiometabolic and oxidative parameters.

Habbout A, Guenancia C, Lorin J, Rigal E, Fassot C, Rochette L, Vergely C.

PLoS One. 2013;8(2):e56981. doi: 10.1371/journal.pone.0056981. Epub 2013 Feb 26.

37.

Postnatal overfeeding in rodents by litter size reduction induces major short- and long-term pathophysiological consequences.

Habbout A, Li N, Rochette L, Vergely C.

J Nutr. 2013 May;143(5):553-62. doi: 10.3945/jn.112.172825. Epub 2013 Feb 27. Review.

PMID:
23446961
38.

Direct and indirect antioxidant properties of α-lipoic acid and therapeutic potential.

Rochette L, Ghibu S, Richard C, Zeller M, Cottin Y, Vergely C.

Mol Nutr Food Res. 2013 Jan;57(1):114-25. doi: 10.1002/mnfr.201200608. Review.

PMID:
23293044
39.

Carbon monoxide: mechanisms of action and potential clinical implications.

Rochette L, Cottin Y, Zeller M, Vergely C.

Pharmacol Ther. 2013 Feb;137(2):133-52. doi: 10.1016/j.pharmthera.2012.09.007. Epub 2012 Sep 29. Review.

40.

Carbon monoxide protects against ischemia-reperfusion injury in vitro via antioxidant properties.

Berne JP, Lauzier B, Rochette L, Vergely C.

Cell Physiol Biochem. 2012;29(3-4):475-84. doi: 10.1159/000338501. Epub 2012 Apr 3.

41.

Mitochondrial basis of the anti-arrhythmic action of lidocaine and modulation by the n-6 to n-3 PUFA ratio of cardiac phospholipids.

Demaison L, Moreau D, Clauw F, Vergely C, Rochette L.

Fundam Clin Pharmacol. 2013 Aug;27(4):373-86. doi: 10.1111/j.1472-8206.2012.01031.x. Epub 2012 Feb 24.

PMID:
22360894
42.

Postnatal overfeeding in rats leads to moderate overweight and to cardiometabolic and oxidative alterations in adulthood.

Habbout A, Delemasure S, Goirand F, Guilland JC, Chabod F, Sediki M, Rochette L, Vergely C.

Biochimie. 2012 Jan;94(1):117-24. doi: 10.1016/j.biochi.2011.09.023. Epub 2011 Oct 1.

PMID:
21978927
43.

Smoking and FOS expression from blood leukocyte transcripts in patients with coronary artery disease.

Saliques S, Teyssier JR, Vergely C, Lorgis L, Lorin J, Donzel A, Sicard P, Berchoud J, Ragot S, Touzery C, Cottin Y, Rochette L, Zeller M.

Atherosclerosis. 2011 Dec;219(2):931-6. doi: 10.1016/j.atherosclerosis.2011.09.026. Epub 2011 Sep 21.

PMID:
21978922
44.

Circulating leukocyte telomere length and oxidative stress: a new target for statin therapy.

Saliques S, Teyssier JR, Vergely C, Lorgis L, Lorin J, Farnier M, Donzel A, Sicard P, Berchoud J, Lagrost AC, Touzery C, Ragot S, Cottin Y, Rochette L, Zeller M.

Atherosclerosis. 2011 Dec;219(2):753-60. doi: 10.1016/j.atherosclerosis.2011.09.011. Epub 2011 Sep 16.

PMID:
21962402
45.

Oxidative stress and myocardial gene alterations associated with Doxorubicin-induced cardiotoxicity in rats persist for 2 months after treatment cessation.

Richard C, Ghibu S, Delemasure-Chalumeau S, Guilland JC, Des Rosiers C, Zeller M, Cottin Y, Rochette L, Vergely C.

J Pharmacol Exp Ther. 2011 Dec;339(3):807-14. doi: 10.1124/jpet.111.185892. Epub 2011 Sep 20.

46.

Cytotoxic dendritic cells generated from cancer patients.

Lakomy D, Janikashvili N, Fraszczak J, Trad M, Audia S, Samson M, Ciudad M, Vinit J, Vergely C, Caillot D, Foucher P, Lagrost L, Chouaib S, Katsanis E, Larmonier N, Bonnotte B.

J Immunol. 2011 Sep 1;187(5):2775-82. doi: 10.4049/jimmunol.1004146. Epub 2011 Jul 29.

47.

[Associated structures in pediatric palliative care, a key factor in patient management].

Vergely C.

Soins Pediatr Pueric. 2011 May-Jun;(260):29. French. No abstract available.

PMID:
21702207
48.

Atrial and vascular oxidative stress in patients with heart failure.

Rochette L, Tatou E, Maupoil V, Zeller M, Cottin Y, Jazayeri S, Brenot R, Girard C, David M, Vergely C.

Cell Physiol Biochem. 2011;27(5):497-502. doi: 10.1159/000329951. Epub 2011 Jun 15.

49.

General oxidative stress during doxorubicin-induced cardiotoxicity in rats: absence of cardioprotection and low antioxidant efficiency of alpha-lipoic acid.

Ghibu S, Delemasure S, Richard C, Guilland JC, Martin L, Gambert S, Rochette L, Vergely C.

Biochimie. 2012 Apr;94(4):932-9. doi: 10.1016/j.biochi.2011.02.015. Epub 2011 Mar 15.

50.

Effect of a chronic cholesterol-rich diet on vascular structure and oxidative stress in LDLR-/- mice.

Lauzier B, Delemasure S, Collin B, Duvillard L, Menetrier F, Vergely C, Connat JL, Rochette L.

Cell Physiol Biochem. 2011;27(1):31-6. doi: 10.1159/000325211. Epub 2011 Feb 11.

Supplemental Content

Loading ...
Support Center